NHSA Updates NRDL Review, Adds Three Domestic Western Medicines
The National Healthcare Security Administration (NHSA) has issued a notification regarding the review and correction...
Policy / Regulatory
China to Enhance Basic Medical Insurance Coverage for Residents in 2024 with Increased Subsidies and Personal Payments
The National Healthcare Security Administration (NHSA), in conjunction with the Ministry of Finance and State...
China’s NHC and NHSA Intensify Efforts to Stabilize Drug Supply and Prices Amid Shortages
The National Health Commission (NHC) has published a report titled “Recent Work on Securing Supply...
China Commits to Optimizing Market Access for Emerging Sectors and Global Scientific Collaboration
The General Office of the Communist Party of China (CPC) Central Committee and the State...
US Congressmen Call for FDA Investigation into Clinical Trials at China’s Military Hospitals
US lawmakers are intensifying their scrutiny of the involvement of Chinese military hospitals in hosting...
China’s VBP Office Exposes Collusion Among Six Firms in Bromhexine Bidding Process
The National Drug Alliance Procurement Office, which oversees the Volume-Based Procurement (VBP) program, has issued...
US Congress Seeks FDA Action on China Military Hospital Trials and Biopharma Security
WASHINGTON—In an unprecedented move, US congressmen have intensified their demands for the US Food and...
China’s National Drug Alliance Procurement Office Imposes Sanctions on Six Firms Over Collusion in Bromhexine Bidding
BEIJING—The National Drug Alliance Procurement Office, which oversees the Volume-Based Procurement (VBP) program, has announced...
NHSA Flags Concerns Over Pricing of MicroPort’s Castor Aortic Stent Graft System
BEIJING—The National Healthcare Security Administration (NHSA) has issued an open letter expressing concerns over the...
Beijing Proposes New Regulations to Enhance Pharmaceutical Retail Standards and Services
The Beijing Municipal Medical Products Administration has unveiled a draft proposal titled “Guiding Opinions on...
Shaanxi Leads New Provincial Alliance for Volume-Based Procurement of Medical Products
The Shaanxi Public Resources Trading Center has announced the formation of a provincial alliance for...
China’s SAMR Proposes Antitrust Guidelines to Regulate Pharmaceutical Industry
The State Administration for Market Regulation (SAMR) in China has unveiled a draft proposal for...
NHSA Preliminary Review Identifies Potential NRDL Additions, Including Novel Therapies and ADCs
The National Healthcare Security Administration (NHSA) has released a preliminary list of drugs that have...
China’s NMPA Proposes New Rules for Export Drug Manufacturing and Management
The National Medical Products Administration (NMPA) of China has issued a new set of regulations...
China’s CDE Seeks Public Comment on Latest Generic Drug Reference Preparations
The Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) is currently...
China’s CDE Releases Draft Guidelines for CAR-T Cell Therapy Clinical Trials
The Center for Drug Evaluation (CDE) in China has issued a draft proposal for “Technical...
China’s NMPA Launches Pilot Programs in Beijing and Shanghai for Innovative Drug Approvals
The National Medical Products Administration (NMPA) of China has given the green light to Beijing...
China’s State Council Unveils Guidelines to Enhance Basic Medical Insurance System
In a bid to address the evolving healthcare needs of an aging population and a...
US Lawmakers Probe Clinical Trials at Hospitals Linked to Chinese Military, Potential Impact on Pharma Industry
Reports from BioCentury and Endpoints News, based on anonymous insider sources, suggest that US lawmakers...
China’s Health Authorities Set Standards for Key Central Township Health Centers
The National Health Commission (NHC), National Disease Control and Prevention Administration, and National Administration of...